Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Matute-Blanch

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Handbook of Clinical Neurology|November 8, 2017
Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous systemClara Matute-Blanch, Xavier Montalban, Manuel Comabella
Journal of Neuroimmunology|November 1, 2020
Modelling multiple sclerosis using induced pluripotent stem cellsJúlia Martínez-Larrosa, Clara Matute-Blanch, Xavier Montalban, et al.
Scientific Reports|April 30, 2020
Chitinase 3-like 1 is neurotoxic in primary cultured neuronsClara Matute-Blanch, Laura Calvo-Barreiro, Iria Carballo-Carbajal, et al.
Clinical and Translational Medicine|December 10, 2024
Chitinase 3-like 1 is neurotoxic in multiple sclerosis patient-derived cortical neuronsRucsanda Pinteac, Jordi Soriano, Clara Matute-Blanch, et al.
Journal of Neuroimmunology|January 9, 2017
Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosisClara Matute-Blanch, Jordi Río, Luisa M Villar, et al.
Epigenomics|December 8, 2020
Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkersMaría Muñoz-San Martín, Sandra Torras, René Robles-Cedeño, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 13, 2021
CSF SERPINA3 Levels Are Elevated in Patients With Progressive MSNicolás Fissolo, Clara Matute-Blanch, Mohamoud Osman, et al.
Clinical and Translational Medicine|May 11, 2022
Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non-cell-autonomous neuronal damageClara Matute-Blanch, Verónica Brito, Luciana Midaglia, et al.
Annals of Neurology|July 7, 2017
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathyNicolas Fissolo, Béatrice Pignolet, Clara Matute-Blanch, et al.
Brain : a Journal of Neurology|February 17, 2018
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndromeClara Matute-Blanch, Luisa M Villar, José C Álvarez-Cermeño, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Handbook of Clinical Neurology|November 8, 2017
Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous systemClara Matute-Blanch, Xavier Montalban, Manuel Comabella
Journal of Neuroimmunology|November 1, 2020
Modelling multiple sclerosis using induced pluripotent stem cellsJúlia Martínez-Larrosa, Clara Matute-Blanch, Xavier Montalban, et al.
Scientific Reports|April 30, 2020
Chitinase 3-like 1 is neurotoxic in primary cultured neuronsClara Matute-Blanch, Laura Calvo-Barreiro, Iria Carballo-Carbajal, et al.
Clinical and Translational Medicine|December 10, 2024
Chitinase 3-like 1 is neurotoxic in multiple sclerosis patient-derived cortical neuronsRucsanda Pinteac, Jordi Soriano, Clara Matute-Blanch, et al.
Journal of Neuroimmunology|January 9, 2017
Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosisClara Matute-Blanch, Jordi Río, Luisa M Villar, et al.
Epigenomics|December 8, 2020
Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkersMaría Muñoz-San Martín, Sandra Torras, René Robles-Cedeño, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 13, 2021
CSF SERPINA3 Levels Are Elevated in Patients With Progressive MSNicolás Fissolo, Clara Matute-Blanch, Mohamoud Osman, et al.
Clinical and Translational Medicine|May 11, 2022
Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non-cell-autonomous neuronal damageClara Matute-Blanch, Verónica Brito, Luciana Midaglia, et al.
Annals of Neurology|July 7, 2017
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathyNicolas Fissolo, Béatrice Pignolet, Clara Matute-Blanch, et al.
Brain : a Journal of Neurology|February 17, 2018
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndromeClara Matute-Blanch, Luisa M Villar, José C Álvarez-Cermeño, et al.
Pageof 2